Hidetoshi Ikeoka

Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients – a Bayesian network meta-analysis

V. Taieb, Hidetoshi Ikeoka, Piotr Wojciechowski et al. · Current Medical Research and Opinion · 2020 · 35 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan

Mariia Dronova, Hidetoshi Ikeoka, Naoya Itsumura et al. · Current Medical Research and Opinion · 2021 · 14 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan

A. Skrzeczek, Hidetoshi Ikeoka, Nobuo Hirotsu et al. · Journal of Infection and Chemotherapy · 2020 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis

Naoki Hosogaya, Takahiro Takazono, Akira Yokomasu et al. · Journal of Medical Economics · 2021 · 11 citations · Full text

Pharmacy, Pharmacotherapy, Cost-utility Analysis +13